US Patent Issued to Janssen Pharmaceutica on Nov. 18 for "Dosing regimens associated with extended release paliperidone injectable formulations" (American, German Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,184, issued on Nov. 18, was assigned to Janssen Pharmaceutica NV (Beerse, Belgium).

"Dosing regimens associated with extended release paliperidone injectable formulations" was invented by Srihari Gopal (Belle Mead, N.J.), Ruth Milz (Cologne, Germany), Steven Wang (Belle Mead, N.J.), Dean Najarian (Wrentham, Mass.), Panna Sanga (Flemington, N.J.) and John Louie (Newark, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides methods of treating patients with long acting injectable paliperidone palmitate formulations. The disclosure includes methods for mitigating at least one adverse change in blood lipid levels of a patien...